Medicine News and Research

RSS

Pathogens and Global Health highlights current debate on counterfeit medicine

The latest issue of Pathogens and Global Health highlights the current debate surrounding the under-investigated, and politically sensitive, issue of counterfeit medicine. Issue 106.2 includes an interview with Dr Paul Newton, Head of the Laos arm of the Wellcome Trust's Major Overseas Programmes, and a number of articles highlighting the technological innovations and field initiatives that are challenging this threat to global health.

13 Sep 2012

ICREA researcher updates latest findings in applied epigenetics

The research team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), professor of genetics at the University of Barcelona and ICREA researcher, has updated the latest findings in applied epigenetics in a review paper published in Nature Reviews Genetics.

13 Sep 2012

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

The Neurodegeneration Consortium (NDC), a transformative multi-institutional initiative, will advance the study and treatment of Alzheimer's and other neurodegenerative diseases, thanks to an inaugural $25 million gift from the Robert A. and Renee E. Belfer Family Foundation to The University of Texas MD Anderson Cancer Center, Baylor College of Medicine and the Massachusetts Institute of Technology (MIT).

13 Sep 2012

Mayo Clinic ‘telestroke’ program will now be available at Casa Grande Regional Medical Center

Pinal County residents in need of emergency medical care for a stroke may benefit from a Mayo Clinic "telestroke" program that will now be available at Casa Grande Regional Medical Center (CGRMC).

13 Sep 2012

Loss of normal microbial diversity may be culprit behind chronic sinusitis

A common bacteria ever-present on the human skin and previously considered harmless, may, in fact, be the culprit behind chronic sinusitis, a painful, recurring swelling of the sinuses that strikes more than one in ten Americans each year, according to a study by scientists at the University of California, San Francisco.

13 Sep 2012

IPS examines controversy over WHO-approved drug to prevent hemorrhage after labor

Inter Press Service examines the reaction to calls for the WHO "to reverse its listing in April 2011 of misoprostol among essential medicines that 'satisfy the health care needs of the majority of the population' and are 'available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford'" as a result of a study published in the August issue of the Journal of the Royal Society of Medicine.

13 Sep 2012

Case Western Reserve researcher discovers new antivirulence drugs against MRSA and strep

Menachem Shoham, PhD, associate professor of biochemistry at Case Western Reserve University School of Medicine, has discovered novel antivirulence drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) and Streptococcus pyogenes, commonly referred to as strep, harmless by preventing the production of toxins that cause disease.

13 Sep 2012

Public health symposium targets smokers most in need

Australia has one of the lowest smoking rates in the world at 15 per cent of the population but there remains a need to further cut rates in prisons, among the mentally ill and ethnic communities, researchers will argue at a public health symposium in Sydney.

13 Sep 2012

AtriCure receives FDA approval for surgical treatment of atrial fibrillation

AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).

13 Sep 2012

Synthetic biology pioneer wins 2012 Heinz Award

Jay Keasling, a leading authority and pioneer on synthetic biology who has engineered microbial "factories" to manufacture an affordable version of a frontline antimalarial drug and biofuel substitutes for gasoline, diesel and jet fuel, has won a 2012 Heinz Award, which is presented by the Heinz Family Foundation and carries with it a cash prize of $250,000.

13 Sep 2012

Viewpoints: Questions Obama, Romney not likely to answer in debates; Disturbing news on tests for ovarian cancer

New evidence that women are more likely to be harmed than helped by screening tests for ovarian cancer is disturbing. The tests do nothing to prevent healthy women from dying from the usually fatal disease. Yet they often lead doctors to perform needless surgeries that cause serious complications in many patients.

13 Sep 2012

Ibuprofen or acetaminophen may increase risk of hearing loss among women

Headache? Back pain? At the first sign of pain, you might reach for a pain-relieving medicine to sooth your bodily woes. Analgesics are the most frequently used medications in the United States and are commonly used to treat a variety of medical conditions. But although popping a pill may make the pain go away, it may do some damage to your ears.

13 Sep 2012

ATA, AACE develop new guidelines for diagnosis and treatment of hypothyroidism

New evidence-based guidelines have been released for the diagnosis and treatment of hypothyroidism, a complex disease caused by an underactive thyroid gland that cannot produce enough thyroid hormone.

13 Sep 2012

Potentially worrisome weight gains following tonsillectomy occur mostly in children under 6

Potentially worrisome weight gains following tonsillectomy occur mostly in children under the age of 6, not in older children, a study by Johns Hopkins experts in otolaryngology- head and neck surgery shows.

13 Sep 2012

Roughly two in five women in the U.S. do not use any form of birth control: Survey

Roughly two in five women in the United States do not use any form of birth control and many underestimate their risk for pregnancy, according to a recent survey about contraceptive practices in the United States.

13 Sep 2012

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing novel antibiotics effective against antibiotic-resistant bacteria, presented new, positive Phase 2 clinical data on its lead drug candidate, eravacycline (TP-434), on September 11, 2012, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

13 Sep 2012

Exercise may affect how people respond to food cues

It is commonly assumed that you can "work up an appetite" with a vigorous workout. Turns out that theory may not be completely accurate - at least immediately following exercise.

13 Sep 2012

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Pfizer Inc., the world's largest research-based pharmaceutical company, and Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, today announced the launch of Hisun-Pfizer Pharmaceuticals Co., Ltd., a joint venture formed between the two companies to develop, manufacture and commercialize off-patent pharmaceutical products in China and global markets.

13 Sep 2012

Alarm raised over preoperative hyponatremia

Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.

12 Sep 2012

Acupuncture therapy remains a prickly matter

Acupuncture may actually be effective for treating some types of chronic pain, a systematic review in the Archives of Internal Medicine shows.

12 Sep 2012

Medicine News and Research

Pathogens and Global Health highlights current debate on counterfeit medicine

ICREA researcher updates latest findings in applied epigenetics

NDC to advance study and treatment of Alzheimer's and other neurodegenerative diseases

Mayo Clinic ‘telestroke’ program will now be available at Casa Grande Regional Medical Center

Loss of normal microbial diversity may be culprit behind chronic sinusitis

IPS examines controversy over WHO-approved drug to prevent hemorrhage after labor

Case Western Reserve researcher discovers new antivirulence drugs against MRSA and strep

Public health symposium targets smokers most in need

AtriCure receives FDA approval for surgical treatment of atrial fibrillation

Synthetic biology pioneer wins 2012 Heinz Award

Viewpoints: Questions Obama, Romney not likely to answer in debates; Disturbing news on tests for ovarian cancer

Ibuprofen or acetaminophen may increase risk of hearing loss among women

ATA, AACE develop new guidelines for diagnosis and treatment of hypothyroidism

Potentially worrisome weight gains following tonsillectomy occur mostly in children under 6

Roughly two in five women in the U.S. do not use any form of birth control: Survey

Positive data from Tetraphase Pharmaceuticals’ eravacycline Phase 2 trial on cIAI

Exercise may affect how people respond to food cues

Zhejiang Hisun Pharmaceuticals, Pfizer launch new joint venture

Alarm raised over preoperative hyponatremia

Acupuncture therapy remains a prickly matter

Everything there is to know about biosimilars eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News